Swiss Precision
Neuropsychiatry

About
We’re on a mission to disrupt the cycle of illness that underlies mental health conditions
Insomnia, anxiety and substance use disorders are among the most prevalent and rapidly growing conditions in mental health. Often rooted in the systemic stresses of modern society their impacts can be devastating.

Current pharmacological standards of care remain woefully inadequate and may provide symptom alleviation with little, if any, impact on the underlying course of the disease.

At Reconnect Labs, we are developing advanced precision therapeutics and predictive diagnostics to break the cycle of illness and maladaptive behaviors that lie at the root of these conditions.

About
About
Precision neuropsychiatry
Our innovative programs are poised to transform the treatment landscape by solving the shortcomings of existing insomnia medicines and the challenges of psychedelic drugs. Engineered with therapeutically precise psychoactive effects and focused molecular targets, our novel formulations are designed to deliver regenerative and cost-effective treatments at scale.

We aim to provide both immediate symptom alleviation and durable, long-term, disease modifying benefits.

About
About
Innovation powered by multi-disciplinary expertise
At Reconnect Labs, we are leveraging our team’s extensive ‘bench to bedside’ experience spanning neuroscience, psychiatry, psychopharmacology, psychedelic science and clinical research to build a platform of drug candidates with the potential to treat multiple sleep, anxiety and substance use disorders.
About

We’d like to
hear from you.

info@reconnect-labs.com

    About Us

    Investors

    Our Work

    ©2024 Reconnect Labs AG. All rights reserved.

    Contact-Block

    We’d like to hear from you.

    info@reconnect-labs.com

      About Us

      Investors

      Our Work

      ©2024 Reconnect Labs AG. All rights reserved.

      Contact-Block